| Alzheimer's disease hypothesis and related therapies |
70 |
| The interplay of aging, genetics and environmental factors in the pathogenesis of Parkinson's disease |
34 |
| The role of statins in both cognitive impairment and protection against dementia: a tale of two mechanisms |
31 |
| Blocking meningeal lymphatic drainage aggravates Parkinson's disease-like pathology in mice overexpressing mutated alpha-synuclein |
25 |
| Intranasal rapamycin ameliorates Alzheimer-like cognitive decline in a mouse model of Down syndrome |
21 |
| Factors that influence adult neurogenesis as potential therapy |
20 |
| Efficient RT-QuIC seeding activity for alpha-synuclein in olfactory mucosa samples of patients with Parkinson's disease and multiple system atrophy |
18 |
| Amyloid, tau, pathogen infection and antimicrobial protection in Alzheimer's disease -conformist, nonconformist, and realistic prospects for AD pathogenesis |
18 |
| Exploratory study on microRNA profiles from plasma-derived extracellular vesicles in Alzheimer's disease and dementia with Lewy bodies |
15 |
| Beyond the synucleinopathies: alpha synuclein as a driving force in neurodegenerative comorbidities |
14 |
| Current progress of mitochondrial transplantation that promotes neuronal regeneration |
13 |
| Exercise-induced increase in brain-derived neurotrophic factor in human Parkinson's disease: a systematic review and meta-analysis |
12 |
| Cerebrospinal fluid phosphorylated tau, visinin-like protein- and chitinase-3-like protein 1 in mild cognitive impairment and Alzheimer's disease |
12 |
| Alpha-synuclein overexpression in the olfactory bulb initiates prodromal symptoms and pathology of Parkinson's disease |
11 |
| Erythrocytic alpha-Synuclein as a potential biomarker for Parkinson's disease |
11 |
| Transcranial direct current stimulation enhances theory of mind in Parkinson's disease patients with mild cognitive impairment: a randomized, double-blind, sham-controlled study |
11 |
| Objective assessment of bradykinesia in Parkinson's disease using evolutionary algorithms: clinical validation |
11 |
| Parkinson's disease in China: a forty-year growing track of bedside work |
11 |
| Hydrogen sulfide, nitric oxide, and neurodegenerative disorders |
10 |
| Aberrant functional connectivity network in subjective memory complaint individuals relates to pathological biomarkers |
9 |
| Microbiome changes: an indicator of Parkinson's disease? |
9 |
| Targeting gamma-secretase triggers the selective enrichment of oligomeric APP-CTFs in brain extracellular vesicles from Alzheimer cell and mouse models |
9 |
| Constipation, deficit in colon contractions and alpha-synuclein inclusions within the colon precede motor abnormalities and neurodegeneration in the central nervous system in a mouse model of alpha-synucleinopathy |
9 |
| Suppression of astrocytic autophagy by alpha B-crystallin contributes to alpha-synuclein inclusion formation |
8 |
| Properties of oscillatory neuronal activity in the basal ganglia and thalamus in patients with Parkinson's disease |
8 |
| Dihydromyricetin and Salvianolic acid B inhibit alpha-synuclein aggregation and enhance chaperone-mediated autophagy |
7 |
| Dynamic changes of CX3CL1/CX3CR1 axis during microglial activation and motor neuron loss in the spinal cord of ALS mouse model |
7 |
| Cerebral glucose metabolic prediction from amnestic mild cognitive impairment to Alzheimer's dementia: a meta-analysis |
6 |
| Longitudinal diffusion tensor magnetic resonance imaging analysis at the cohort level reveals disturbed cortical and callosal microstructure with spared corticospinal tract in the TDP-43(G298S) ALS mouse model |
6 |
| Lower serum expression of miR-181c-5p is associated with increased plasma levels of amyloid-beta 1-40 and cerebral vulnerability in normal aging |
5 |
| A longitudinal assessment of retinal function and structure in the APP/PS1 transgenic mouse model of Alzheimer's disease |
5 |
| Ultra-High Field Diffusion MRI Reveals Early Axonal Pathology in Spinal Cord of ALS mice |
5 |
| Detecting neurodegenerative pathology in multiple sclerosis before irreversible brain tissue loss sets in |
5 |
| Xenografting of human umbilical mesenchymal stem cells from Wharton's jelly ameliorates mouse spinocerebellar ataxia type 1 |
5 |
| Age-dependent alpha-synuclein accumulation and aggregation in the colon of a transgenic mouse model of Parkinson's disease |
4 |
| NF-kappa B/c-Rel deficiency causes Parkinson' disease-like prodromal symptoms and progressive pathology in mice |
4 |
| Direct conversion of mouse astrocytes into neural progenitor cells and specific lineages of neurons |
4 |
| Oral administration of the cannabigerol derivative VCE-003.2 promotes subventricular zone neurogenesis and protects against mutant huntingtin-induced neurodegeneration |
4 |
| No association between Parkinson disease and autoantibodies against NMDA-type glutamate receptors |
4 |
| Cognitive decline is related to high blood glucose levels in older Chinese adults with the ApoE epsilon 3/epsilon 3 genotype |
4 |
| Molecular targets for modulating the protein translation vital to proteostasis and neuron degeneration in Parkinson's disease |
4 |
| Better survival in female SOD1-mutant patients with ALS: a study of SOD1-related natural history |
4 |
| Clinical features and genetic spectrum in Chinese patients with recessive hereditary spastic paraplegia |
4 |
| Neurodegeneration-associated FUS is a novel regulator of circadian gene expression |
4 |
| Rare TBK1 variants in patients with frontotemporal dementia and amyotrophic lateral sclerosis in a Chinese cohort |
3 |
| Impact of the biological definition of Alzheimer's disease using amyloid, tau and neurodegeneration (ATN): what about the role of vascular changes, inflammation, Lewy body pathology? |
3 |
| Surfen and oxalyl surfen decrease tau hyperphosphorylation and mitigate neuron deficits in vivo in a zebrafish model of tauopathy |
3 |
| Enriched gestation activates the IGF pathway to evoke embryo-adult benefits to prevent Alzheimer's disease |
3 |
| Clinicopathologic characterization and abnormal autophagy of CSF1R-related leukoencephalopathy |
3 |
| GM604 regulates developmental neurogenesis pathways and the expression of genes associated with amyotrophic lateral sclerosis |
3 |
